Literature DB >> 1401443

The relationship between level of mandibular pain and dysfunction and stage of temporomandibular joint internal derangement.

E L Schiffman1, G C Anderson, J R Fricton, B R Lindgren.   

Abstract

Temporomandibular joint internal derangement (TMJ ID) is the most common intra-articular TM disorder and can progress from TMJ ID with reduction to TMJ ID without reduction. It is not known whether this anatomical progression is associated with increasing levels of mandibular dysfunction. The objective of this study was to determine whether the level of clinically detectable mandibular dysfunction was related to the stage of TMJ ID. Two clinicians examined 42 subjects prior to bilateral TMJ arthrographic evaluation. The level of mandibular dysfunction was calculated by Helkimo's Clinical Dysfunction Index (Di) and the Craniomandibular Index (CMI). Statistical analysis revealed that the level of mandibular dysfunction as determined by the Di and CMI was not related to the arthrographic presence or absence of TMJ ID. Therefore, the clinician cannot assume that the level of mandibular dysfunction is directly related to the absence or presence of TMJ ID. Epidemiologically, the CMI and Di can be used only for estimation of the degree of mandibular dysfunction, since they do not provide direct information on a specific TM disorder.

Entities:  

Mesh:

Year:  1992        PMID: 1401443     DOI: 10.1177/00220345920710110901

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  3 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1993

2.  Temporomandibular joint disorders' impact on pain, function, and disability.

Authors:  P Chantaracherd; M T John; J S Hodges; E L Schiffman
Journal:  J Dent Res       Date:  2015-01-08       Impact factor: 6.116

3.  Self-reported severity of taste disturbances correlates with dysfunctional grade of TMD pain.

Authors:  D R Nixdorf; M T John; O Schierz; D A Bereiter; G Hellekant
Journal:  J Oral Rehabil       Date:  2009-09-11       Impact factor: 3.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.